Literature DB >> 4268512

Biochemical "defect" in the hypertrophied and failing heart: deleterious or compensatory?

A M Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4268512     DOI： 10.1161/01.cir.47.5.1076

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

Review 1.  Digoxin after myocardial infarction. Does it have a role?

Authors:  G D Johnston
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 2.  Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart.

Authors:  A M Katz
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

3.  Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice.

Authors:  M Kuhn; R Holtwick; H A Baba; J C Perriard; W Schmitz; E Ehler
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

4.  The mortality risk associated with digitalis treatment after myocardial infarction.

Authors:  A J Moss; J T Bigger; E Carleen; J L Fleiss; C L Odoroff; L Rolnitzky; T Therneau
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

Review 5.  Cardiogenic shock.

Authors:  C E Handler
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

6.  Amrinone--promising innovation for treatment of the failing heart.

Authors:  R Hayward
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

7.  The paradox of the lack of the efficacy of digitalis in congestive heart failure with sinus rhythm.

Authors:  J Hamer
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

8.  The effect of chronic digitoxin administration on the contractile state of normal and nonfailing hypertrophied myocardium.

Authors:  J F Williams; R D Potter
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 9.  Reassessment of digoxin and other low-dose positive inotropes in the treatment of chronic heart failure.

Authors:  J Tauke; D Han; M Gheorghiade
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

10.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.